Skip to main content
. 2021 Aug 17;45(2):399–411. doi: 10.1007/s40618-021-01660-y

Table 1.

Percent of modulated genes in functioning nodule (FN) and non-functioning nodule (NN) of patient #1 and #2

Patient #1 Patient #2
FN NN FN NN
% Increase 8.9 5.4 6.0 1.3
% Decrease 8.4 6.5 8.9 5.3
% Total change 17.3 11.9 14.9 6.6